Centro de Salud Leganitos
- Address
- Plaza de Leganitos 5, 29601 Marbella, Spain
Centro de Salud Leganitos - HIV Treatment Innovation
Centro de Salud Leganitos is a healthcare facility engaged in innovative HIV treatment research, with particular emphasis on improving patient access to advanced therapeutic options. The center specializes in evaluating novel administration strategies for long-acting antiretroviral therapies in HIV-infected patients.
- Out-of-hospital administration of long-acting HIV medications
- Patient-centered approaches to antiretroviral therapy delivery
- Safety and tolerability assessment of combination HIV treatments
The center's research focus includes the implementation of long-acting cabotegravir and rilpivirine combination therapy in alternative healthcare settings. Their work evaluates critical factors such as acceptability, appropriateness, feasibility, and patient satisfaction when administering advanced HIV treatments outside traditional hospital environments, aiming to improve treatment accessibility and quality of life for people living with HIV.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro de Salud Leganitos
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Long-Acting Cabotegravir and Rilpivirine Administration in HIV-Infected Patients in Spain: Acceptability, Safety, and Feasibility Analysis | Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La Ciencia | Phase III | Not Recruiting | Oct 2023 | May 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cabotegravir | 1 | Unknown | 2023-10-05 | 2023-10-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.